Eating a Mediterranean diet and consuming caffeine may lower the risk of age-related macular degeneration (AMD), according to a study presented at the annual meeting of the American Academy of Ophthalmology, held in Chicago.
For patients with advanced retinoblastoma, topotecan combined with vincristine, carboplatin, and aggressive focal therapies is effective, according to a study published online in the Journal of Clinical Oncology.
Allergan announced the submission of a de novo application to the Food and Drug Administration (FDA) for the Oculeve Intranasal Tear Neurostimulator device.
Women who undergo a corneal transplant may have a worse outcome if their donor is male, according to a study published online July 14 in the American Journal of Transplantation.
Shire announced that the Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5% for the treatment of the signs and symptoms of dry eye disease in adults. This is the first prescription ophthalmic solution approved to treat both signs and symptoms of this condition.
ThromboGenics announced that the Food and Drug Administration (FDA) has approved a new "already-diluted" formulation of Jetrea (ocriplasmin) intravitreal injection.
Combigan (brimonidine tartrate, timolol maleate; Allergan) ophthalmic solution is now available in a new 15mL bottle size for a 90-day supply.
As baby boomers age, the number of Americans with visual impairment and blindness is expected to double over the next 3 decades, according to a study published online in JAMA Ophthalmology.
In a case report published online April 30 in Clinical & Experimental Ophthalmology, venlafaxine-induced increase in intraocular pressure (IOP) is described in a patient with open angle glaucoma.
A device mounted onto eyeglasses enables people considered legally blind to "read" and perform other day-to-day activities, according to a study published online in JAMA Ophthalmology.